WallStreetZenWallStreetZen

NASDAQ: NRXP
Nrx Pharmaceuticals Inc Stock Ownership - Who owns Nrx Pharmaceuticals?

Insider buying vs selling

Have Nrx Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Aaron GorovitzDirector2023-08-3035,000$0.32
$11.20kBuy
Chaim HurvitzDirector2023-08-3070,000$0.29
$20.09kBuy
Jonathan C. JavittChief Scientist2023-08-23100,000$0.33
$33.00kBuy
Jonathan C. JavittChief Scientist2023-08-22200,000$0.32
$64.40kBuy

1 of 1

NRXP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRXP insiders and whales buy or sell their stock.

NRXP Shareholders

What type of owners hold Nrx Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Jonathan C. Javitt305.50%29,236,658$88.88MInsider
Daniel C. Javitt246.67%23,606,657$71.76MInsider
Chaim Hurvitz25.32%2,423,236$7.37MInsider
Brac Lending Group LLC23.29%2,228,435$6.77MInsider
Vanguard Group Inc15.10%1,445,177$4.39MInstitution
Polar Asset Management Partners Inc10.51%1,005,536$3.06MInsider
Advisorshares Investments LLC6.72%642,632$1.95MInstitution
Big Rock Partners Sponsor LLC5.43%519,315$1.58MInsider
Geode Capital Management LLC4.30%411,922$1.25MInstitution
Patrick John Flynn4.22%404,291$1.23MInsider

1 of 3

NRXP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRXP6.23%93.77%Net Buying
SPRB63.59%36.41%Net SellingNet Selling
IGC3.87%20.14%
LEXX8.82%4.82%
APM0.85%40.28%

Nrx Pharmaceuticals Stock Ownership FAQ

Who owns Nrx Pharmaceuticals?

Nrx Pharmaceuticals (NASDAQ: NRXP) is owned by 41.70% institutional shareholders, 627.51% Nrx Pharmaceuticals insiders, and 0.00% retail investors. Jonathan C. Javitt is the largest individual Nrx Pharmaceuticals shareholder, owning 29.24M shares representing 305.50% of the company. Jonathan C. Javitt's Nrx Pharmaceuticals shares are currently valued at $87.71M.

If you're new to stock investing, here's how to buy Nrx Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.